Issaquah, WA, United States of America

Mark W Rixon

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 166(Granted Patents)


Location History:

  • Midland, MI (US) (1995 - 2001)
  • Issaquah, WA (US) (2001 - 2022)
  • Seattle, WA (US) (2017 - 2022)

Company Filing History:


Years Active: 1995-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Immunomodulatory Proteins
Monoclonal Antibodies
Bispecific Antibodies
TACI-Immunoglobulin Fusion Proteins
Soluble Hybrid Fc Receptors
Inflammation Treatment
Polynucleotides Encoding Antibodies
Interleukin-20 Receptor
Interferon-Epsilon
Cancer Treatment
B Cell Cancers
Antibody Specificity
43 patents (USPTO):Explore Patents

Title: The Innovative Journey of Mark W. Rixon: Pioneering Immunomodulatory Proteins

Introduction: Mark W. Rixon, based in Issaquah, WA, is a remarkable inventor with an impressive portfolio of 42 patents. His work primarily focuses on immunomodulatory proteins, contributing significantly to the field of biomedical innovation.

Latest Patents: Among his recent groundbreaking patents are those related to APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof. These innovative proteins exhibit neutralizing activity against BAFF and APRIL heterotrimers. The patents describe immunomodulatory proteins, including variant domains of Transmembrane Activator and CAML Interactor (TACI) and TACI-Fc fusion proteins. Furthermore, the patents encompass nucleic acid molecules encoding these proteins, underscoring their therapeutic utility for various immunological diseases, disorders, and conditions. The compositions and methods detailed offer significant insights into making and utilizing these proteins effectively.

Career Highlights: Mark W. Rixon has held notable positions in influential companies such as Zymogenetics, Inc. and The Dow Chemical Company. His work has enhanced the understanding of immunomodulation and has the potential to lead to groundbreaking treatments.

Collaborations: Throughout his career, Mark has collaborated with distinguished colleagues, including Scott R. Presnell and Jane A. Gross. These collaborations have fostered a conducive environment for innovation and development in the biomedical field.

Conclusion: Mark W. Rixon's contributions to the field of immunology and his extensive patent portfolio reflect his dedication to advancing medical science. His innovations in immunomodulatory proteins promise to pave the way for new therapeutic strategies in treating a variety of immunological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…